Loading...
Castle Biosciences, Inc.
CSTL•NASDAQ
Healthcare
Medical - Diagnostics & Research
$16.07
$-0.36(-2.19%)
Castle Biosciences, Inc. (CSTL) Financial Performance & Income Statement Overview
Review Castle Biosciences, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
51.09%
↑ 51.09%
Operating Income Growth
112.75%
↑ 112.75%
Net Income Growth
131.75%
↑ 131.75%
Operating Cash Flow Growth
1252.97%
↑ 1252.97%
Operating Margin
-3.97%
↓ 3.97%
Gross Margin
85.88%
↑ 85.88%
Net Profit Margin
-1.46%
↓ 1.46%
ROE
-1.15%
↓ 1.15%
ROIC
-2.97%
↓ 2.97%
Castle Biosciences, Inc. (CSTL) Income Statement & Financial Overview
Review Castle Biosciences, Inc.'s (CSTL) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $86.31M | $85.78M | $87.002M | $72.97M |
| Cost of Revenue | $16.18M | $15.61M | $17.23M | $16.58M |
| Gross Profit | $70.13M | $70.17M | $69.77M | $56.40M |
| Gross Profit Ratio | $0.81 | $0.82 | $0.80 | $0.77 |
| R&D Expenses | $11.77M | $12.32M | $14.05M | $13.46M |
| SG&A Expenses | $49.97M | $50.50M | $50.71M | $48.41M |
| Operating Expenses | $66.08M | $65.09M | $64.76M | $61.87M |
| Total Costs & Expenses | $82.26M | $80.70M | $81.99M | $78.44M |
| Interest Income | $3.37M | $3.40M | $3.14M | $3.00M |
| Interest Expense | $92000.00 | $201000.00 | $270000.00 | $14000.00 |
| Depreciation & Amortization | $5.77M | $3.54M | $3.35M | $3.34M |
| EBITDA | $13.74M | $12.02M | $11.50M | $865000.00 |
| EBITDA Ratio | $0.16 | $0.14 | $0.13 | $0.01 |
| Operating Income | $4.05M | $5.08M | $5.01M | -$5.47M |
| Operating Income Ratio | $0.05 | $0.06 | $0.06 | -$0.07 |
| Other Income/Expenses (Net) | $3.83M | $3.20M | $2.87M | $2.98M |
| Income Before Tax | $7.88M | $8.28M | $7.89M | -$2.49M |
| Income Before Tax Ratio | $0.09 | $0.10 | $0.09 | -$0.03 |
| Income Tax Expense | -$1.71M | $6.01M | -$1.03M | $45000.00 |
| Net Income | $9.59M | $2.27M | $8.92M | -$2.53M |
| Net Income Ratio | $0.11 | $0.03 | $0.10 | -$0.03 |
| EPS | $0.34 | $0.08 | $0.32 | -$0.09 |
| Diluted EPS | $0.32 | $0.08 | $0.31 | -$0.09 |
| Weighted Avg Shares Outstanding | $28.13M | $27.84M | $27.65M | $27.48M |
| Weighted Avg Shares Outstanding (Diluted) | $30.20M | $29.40M | $28.74M | $27.48M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan